The following table sets forth the gross carrying amount, accumulated amortization and net carrying amount of our intangible assets as of December 31, 2019 and 2018: (Details) - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Accumulated Amortization	$ (478,983)	$ (384,712)
Intangible Assets, Gross (Excluding Goodwill)	5,737,194	4,477,391
Intangible Assets, Net (Excluding Goodwill)	5,258,211	4,092,679
Hormone Therapy Drug Candidate Patents - (Pending) [Member]
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Gross	1,979,299	1,855,279
Finite-Lived Intangible Assets, Net	1,979,299	1,855,279
Multiple Trademarks [Member]
Finite-Lived Intangible Assets [Line Items]
Indefinite-Lived Trademarks	294,813	264,289
Indefinite-lived Intangible Assets (Excluding Goodwill)	294,813	264,289
Approved Hormone Therapy Drug Candidate Patents [Member]
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Gross	3,463,082	2,234,129
Finite-Lived Intangible Assets, Accumulated Amortization	(478,983)	(282,485)
Finite-Lived Intangible Assets, Net	$ 2,984,099	$ 1,951,644
Finite-Lived Intangible Assets, Remaining Amortization Period	13 years	14 years
Computer Software, Intangible Asset [Member]
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Gross		$ 31,951
Finite-Lived Intangible Assets, Accumulated Amortization		(10,484)
Finite-Lived Intangible Assets, Net		$ 21,467
Finite-Lived Intangible Assets, Remaining Amortization Period		10 years 9 months
Internet Domain Names [Member]
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Gross		$ 91,743
Finite-Lived Intangible Assets, Accumulated Amortization		$ (91,743)